Certara, Inc. Common Stock (CERT)
Price trend score is near the top of its range.
CERT scores higher than 83% of the 1,101 tickers we compare it with (Health Care).
As of 9 October 2026, Certara, Inc. Common Stock (CERT) scores 59 out of 100 on the Market Census six-factor composite, which puts it at the Above average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 1.85× 30-day average
- 52-week range
- 4.45 – 13.12
- Market cap
- $1.28B
- Earnings date
- 2 Nov 2026
- Volume
- 5,033,859
- Avg. volume (30d)
- 2,723,344
- Open
- 8.85
- Previous close
- 8.64
- Day's range (regular session)
- 8.64 – 9.27
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 1.28
- P/E (TTM)
- —
- EPS (TTM)
- -0.44
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
What the score says about CERT right now
Certara, Inc. Common Stock (CERT) currently scores 59/100 on the Market Census six-factor composite, at the Above average score level. CERT is +5.67% on the day and -1.87% over five sessions as of the most recent tick. Above average sits a bit above the middle. The data for CERT leans good, with some weak spots. CERT's strongest factor is price trend at 85/100 — a very strong read on which way the price has been going. The weakest factor is company finances at 44/100 — middling company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See CERT in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent CERT news
Latest headlines that name Certara, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- In-Silico Drug Discovery Market Report Now Available: Capitalize on AI-led R&D disruption as revenue surges from $3.3B to $6B by 2030; benchmark Certara, Insilico Medicine, Isomorphic Labs, Exscientia and BenevolentAI to secure share.Yahoo
- Capitalize on Drug Discovery Informatics: Benchmark Schrödinger, Certara, Dotmatics, Thermo Fisher and BIOVIA to Accelerate R&D ROI and Secure Market AdvantageYahoo
- Capitalize on Biosimulation’s R&D Disruption: Benchmark Certara, Simulations Plus, Dassault Systèmes, Schrödinger and Applied BioMath to Accelerate Drug Pipelines and Secure ROIYahoo
- Certara (CERT) Slashes Jobs While Doubling Down On Software GrowthYahoo
- Cerrado Gold Closes $10 Million Strategic Private Placement with Eric SprottYahoo
We hide 3 more that told readers to buy or sell, or gave a price target.
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to CERT’s 59, all within 1 point.
Sorted by closeness to CERT’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.